Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.

Vibrio cholerae O1 biotype El Tor (ET), causing the seventh cholera pandemic, was recently replaced in Bangladesh by an altered ET possessing ctxB of the Classical (CL) biotype, which caused the first six cholera pandemics. In the present study, V. cholerae O1 strains associated with endemic cholera in Dhaka between 2006 and 2011 were analysed for major phenotypic and genetic characteristics. Of 54 representative V. cholerae isolates tested, all were phenotypically ET and showed uniform resistance to trimethoprim/sulfamethoxazole (SXT) and furazolidone (FR). Resistance to tetracycline (TE) and erythromycin (E) showed temporal fluctuation, varying from year to year, while all isolates were susceptible to gentamicin (CN) and ciprofloxacin (CIP). Year-wise data revealed erythromycin resistance to be 33.3 % in 2006 and 11 % in 2011, while tetracycline resistance accounted for 33, 78, 0, 100 and 27 % in 2006, 2007, 2008, 2009 and 2010, respectively; interestingly, all isolates tested were sensitive to TE in 2011, as observed in 2008. All V. cholerae isolates tested possessed genetic elements such as SXT, ctxAB, tcpA(ET), rstR(ET) and rtxC; none had IntlI (Integron I). Double mismatch amplification mutation assay (DMAMA)-PCR followed by DNA sequencing and analysis of the ctxB gene revealed a point mutation at position 58 (C→A), which has resulted in an amino acid substitution from histidine (H) to asparagine (N) at position 20 (genotype 7) since 2008. Although the multi-resistant strains having tetracycline resistance showed minor genetic divergence, V. cholerae strains were clonal, as determined by a PFGE (NotI)-based dendrogram. This study shows 2008-2010 to be the time of transition from ctxB genotype 1 to genotype 7 in V. cholerae ET causing endemic cholera in Dhaka, Bangladesh.

[1]  Y. Takeda,et al.  Development and Evaluation of a PCR Assay for Tracking the Emergence and Dissemination of Haitian Variant ctxB in Vibrio cholerae O1 Strains Isolated from Kolkata, India , 2012, Journal of Clinical Microbiology.

[2]  A. Vicente,et al.  Variants of Vibrio cholerae O1 El Tor from Zambia showed new genotypes of ctxB , 2011, Epidemiology and Infection.

[3]  N. A. Bhuiyan,et al.  Variants of Vibrio cholerae O1 El Tor from Zambia showed new genotypes of ctxB: a reply to Marin & Vicente , 2011, Epidemiology and Infection.

[4]  Julian Parkhill,et al.  Evidence for several waves of global transmission in the seventh cholera pandemic , 2011, Nature.

[5]  M. Jain,et al.  Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India. , 2011, Acta tropica.

[6]  James H. Bullard,et al.  The origin of the Haitian cholera outbreak strain. , 2011, The New England journal of medicine.

[7]  M. Quilici,et al.  Vibrio cholerae O1 Variant with Reduced Susceptibility to Ciprofloxacin, Western Africa , 2010, Emerging infectious diseases.

[8]  N. Taneja,et al.  Emergence of tetracycline resistance in Vibrio cholerae O1 biotype El Tor serotype Ogawa from north India. , 2010, Indian journal of pathology & microbiology.

[9]  A. Goel,et al.  Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[10]  Armando Navarro,et al.  Cholera between 1991 and 1997 in Mexico Was Associated with Infection by Classical, El Tor, and El Tor Variants of Vibrio cholerae , 2010, Journal of Clinical Microbiology.

[11]  Sabu Thomas,et al.  Characterization of an SXT variant Vibrio cholerae O1 Ogawa isolated from a patient in Trivandrum, India. , 2010, FEMS microbiology letters.

[12]  Bradd J. Haley,et al.  Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic Vibrio cholerae , 2009, Proceedings of the National Academy of Sciences.

[13]  A. Nizam,et al.  El Tor cholera with severe disease: a new threat to Asia and beyond , 2009, Epidemiology and Infection.

[14]  G. Nair,et al.  A large cholera outbreak due to a new cholera toxin variant of the Vibrio cholerae O1 El Tor biotype in Orissa, Eastern India. , 2009, Journal of medical microbiology.

[15]  A. Safa,et al.  Vibrio cholerae O1 Hybrid El Tor Strains, Asia and Africa , 2008, Emerging infectious diseases.

[16]  R. Colwell,et al.  Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission , 2007, Proceedings of the National Academy of Sciences.

[17]  M. A. Malek,et al.  Emergence of Multidrug-resistant Strain of Vibrio cholerae O1 in Bangladesh and Reversal of Their Susceptibility to Tetracycline after Two Years , 2007, Journal of health, population, and nutrition.

[18]  Y. Takeda,et al.  Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh , 2006, Journal of Clinical Microbiology.

[19]  M. Bennish,et al.  Single-dose azithromycin for the treatment of cholera in adults. , 2006, The New England journal of medicine.

[20]  Anwar Huq,et al.  Seasonal Cholera Caused by Vibrio cholerae Serogroups O1 and O139 in the Coastal Aquatic Environment of Bangladesh , 2006, Applied and Environmental Microbiology.

[21]  J. Terajima,et al.  Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae. , 2006, Foodborne pathogens and disease.

[22]  Amita,et al.  Occurrence of Antibiotic Resistance Gene Cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in Class I Integrons in Non-O1, Non-O139 Vibrio cholerae Strains in India , 2002, Antimicrobial Agents and Chemotherapy.

[23]  D. Sack,et al.  New Variants of Vibrio cholerae O1 Biotype El Tor with Attributes of the Classical Biotype from Hospitalized Patients with Acute Diarrhea in Bangladesh , 2002, Journal of Clinical Microbiology.

[24]  John F. Heidelberg,et al.  Comparative genomic analysis of Vibrio cholerae: Genes that correlate with cholera endemic and pandemic disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Yuen,et al.  Detection of RTX Toxin Gene in Vibrio cholerae by PCR , 2001, Journal of Clinical Microbiology.

[26]  Amit Ghosh,et al.  Diverse CTXΦs and evolution of new pathogenic Vibrio cholerae , 1998, The Lancet.

[27]  S. Yamasaki,et al.  Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. , 1998, FEMS immunology and medical microbiology.

[28]  M. Waldor,et al.  A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139 , 1996, Journal of bacteriology.

[29]  Amit Pal,et al.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India , 1993, The Lancet.

[30]  T. Popović,et al.  Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains , 1993, Journal of clinical microbiology.

[31]  C. Pazzani,et al.  Clonal spread of multiply resistant strains of Vibrio cholerae O1 in Somalia. , 1986, The Journal of infectious diseases.

[32]  R. Glass,et al.  Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh. , 1983, The Journal of infectious diseases.

[33]  R. Glass,et al.  Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. , 1980, The Journal of infectious diseases.

[34]  F. Mhalu,et al.  RAPID EMERGENCE OF EL TOR VIBRIO CHOLERA RESISTANT TO ANTIMICROBIAL AGENTS DURING FIRST SIX MONTHS OF FOURTH CHOLERA EPIDEMIC IN TANZANIA , 1979, The Lancet.

[35]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[36]  A. Benenson,et al.  TETRACYCLINE IN THE TREATMENT OF CHOLERA. , 1964, Lancet.

[37]  Samir N. Patel,et al.  Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .

[38]  S. Faruque,et al.  Aetiological, clinical and epidemiological characteristics of a seasonal peak of diarrhoea in Dhaka, Bangladesh. , 1998, Scandinavian journal of infectious diseases.

[39]  Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. , 1993, Lancet.

[40]  M. Jesudason,et al.  Transferable trimethoprim resistance of Vibrio cholerae O1 encountered in southern India. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  M. Islam,et al.  Antibiotic therapy of cholera. , 1967, Bulletin of the World Health Organization.